Cargando…

Immunosuppressive Roles of Galectin-1 in the Tumor Microenvironment

Evasion of immune surveillance is an accepted hallmark of tumor progression. The production of immune suppressive mediators by tumor cells is one of the major mechanisms of tumor immune escape. Galectin-1 (Gal-1), a pivotal immunosuppressive molecule, is expressed by many types of cancer. Tumor-secr...

Descripción completa

Detalles Bibliográficos
Autores principales:	Huang, Yanyu, Wang, Hsiao-Chi, Zhao, Junwei, Wu, Ming-Heng, Shih, Tsung-Chieh
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8533562/ https://www.ncbi.nlm.nih.gov/pubmed/34680031 http://dx.doi.org/10.3390/biom11101398

Ejemplares similares

The role of Galectin-3 in modulating tumor growth and immunosuppression within the tumor microenvironment
por: Farhad, Mohammad, et al.
Publicado: (2018)

Galectins in Cancer and the Microenvironment: Functional Roles, Therapeutic Developments, and Perspectives
por: Li, Chien-Hsiu, et al.
Publicado: (2021)

Role of Galectins in Tumors and in Clinical Immunotherapy
por: Chou, Feng-Cheng, et al.
Publicado: (2018)

The roles of curcumin in regulating the tumor immunosuppressive microenvironment
por: Wang, Yizhi, et al.
Publicado: (2020)

Exosome-Mediated Immunosuppression in Tumor Microenvironments
por: Xie, Qi-Hui, et al.
Publicado: (2022)

Delineating the "galectin signature" of the tumor microenvironment
por: Compagno, Daniel, et al.
Publicado: (2013)

Tumor-intrinsic signaling pathways: key roles in the regulation of the immunosuppressive tumor microenvironment
por: Yang, Li, et al.
Publicado: (2019)

The role of hypoxia in shaping the recruitment of proangiogenic and immunosuppressive cells in the tumor microenvironment
por: Chouaib, Salem, et al.
Publicado: (2018)

Overcoming the Immunosuppressive Tumor Microenvironment in Multiple Myeloma
por: Uckun, Fatih M.
Publicado: (2021)

Harnessing nanomedicine to overcome the immunosuppressive tumor microenvironment
por: Sun, Bo, et al.
Publicado: (2020)

Galectin-1: A Traditionally Immunosuppressive Protein Displays Context-Dependent Capacities
por: Yu, Xizhi, et al.
Publicado: (2023)

Role of the immunosuppressive microenvironment in immunotherapy
por: Tormoen, Garth W., et al.
Publicado: (2018)

Immunosuppressive Tumor Microenvironment and Immunotherapy of Epstein–Barr Virus-Associated Malignancies
por: Zheng, Xueyi, et al.
Publicado: (2022)

Prognostic Significance of Galectin-1 but Not Galectin-3 in Patients With Lung Adenocarcinoma After Radiation Therapy
por: Huang, Chun-Chieh, et al.
Publicado: (2022)

GARP: A Key Target to Evaluate Tumor Immunosuppressive Microenvironment
por: Bouchard, Alexanne, et al.
Publicado: (2021)

Context-Specific Determinants of the Immunosuppressive Tumor Microenvironment in Pancreatic Cancer
por: Falcomatà, Chiara, et al.
Publicado: (2023)

Thwarting galectin-induced immunosuppression in breast cancer
por: Salatino, Mariana, et al.
Publicado: (2013)

Extracellular Vesicles (Exosomes) as Immunosuppressive Mediating Variables in Tumor and Chronic Inflammatory Microenvironments
por: Awadasseid, Annoor, et al.
Publicado: (2021)

Is there a causal link between PTEN deficient tumors and immunosuppressive tumor microenvironment?
por: Cetintas, Vildan B., et al.
Publicado: (2020)

Tumor Microenvironment Immunosuppression: A Roadblock to CAR T-Cell Advancement in Solid Tumors
por: Johnson, Abigail, et al.
Publicado: (2022)

Sugars boost exhausted tumor-infiltrating lymphocytes by counteracting immunosuppressive activities of galectins
por: Gordon-Alonso, Monica, et al.
Publicado: (2014)

The IL4I1 Enzyme: A New Player in the Immunosuppressive Tumor Microenvironment
por: Molinier-Frenkel, Valérie, et al.
Publicado: (2019)

Features of the immunosuppressive tumor microenvironment in endometrial cancer based on molecular subtype
por: Zhang, Chong, et al.
Publicado: (2023)

Functional Regulation of Ginsenosides on Myeloid Immunosuppressive Cells in the Tumor Microenvironment
por: Zhang, Yanfei, et al.
Publicado: (2019)

TA-MSCs, TA-MSCs-EVs, MIF: their crosstalk in immunosuppressive tumor microenvironment
por: Zhang, Zhenghou, et al.
Publicado: (2022)

Role of galectins in lung cancer
por: Chang, Wei-An, et al.
Publicado: (2017)

The Role of Galectin-1 in Cancer Progression, and Synthetic Multivalent Systems for the Study of Galectin-1
por: Cousin, Jonathan M., et al.
Publicado: (2016)

Current perspectives on the immunosuppressive tumor microenvironment in hepatocellular carcinoma: challenges and opportunities
por: Lu, Chen, et al.
Publicado: (2019)

Tumor Immune Microenvironment and Immunosuppressive Therapy in Hepatocellular Carcinoma: A Review
por: Oura, Kyoko, et al.
Publicado: (2021)

Targeted nanomedicines remodeling immunosuppressive tumor microenvironment for enhanced cancer immunotherapy
por: Xu, Yanyan, et al.
Publicado: (2022)

Long Non-coding RNAs: Emerging Roles in the Immunosuppressive Tumor Microenvironment
por: Luo, Ya, et al.
Publicado: (2020)

Galectin-3 Determines Tumor Cell Adaptive Strategies in Stressed Tumor Microenvironments
por: Cardoso, Ana Carolina Ferreira, et al.
Publicado: (2016)

Reversal of the immunosuppressive tumor microenvironment by nanoparticle-based activation of immune-associated cells
por: Qi, Fei-long, et al.
Publicado: (2020)

Autophagy in the Immunosuppressive Perivascular Microenvironment of Glioblastoma
por: Molina, Maria L., et al.
Publicado: (2019)

Immunosuppressive mechanisms of oncofetal reprogramming in the tumor microenvironment: implications in immunotherapy response
por: Currenti, Jennifer, et al.
Publicado: (2023)

BAFF Attenuates Immunosuppressive Monocytes in the Melanoma Tumor Microenvironment
por: Liu, Wei, et al.
Publicado: (2022)

Neddylation: a novel modulator of the tumor microenvironment
por: Zhou, Lisha, et al.
Publicado: (2019)

Therapeutic challenges and current immunomodulatory strategies in targeting the immunosuppressive pancreatic tumor microenvironment
por: Looi, Chin-King, et al.
Publicado: (2019)

Chimeric Antigen Receptor T cell Therapy and the Immunosuppressive Tumor Microenvironment in Pediatric Sarcoma
por: Terry, Rachael L., et al.
Publicado: (2021)

Oncolytic virotherapy reverses the immunosuppressive tumor microenvironment and its potential in combination with immunotherapy
por: Zhang, Yalei, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_q5ksgq4cpo68b5msnr8bj27s6c